Insulet Q3 2023 revenue $432.7M (+27% YoY); raises FY revenue guidance to 26-27% growth

INSULET CORP

2023-Q3 EPS reported $1.47 revenue$1,187,300,000

Revenue $432.7M (+27% YoY); U.S. Omnipod $320.6M (+34.6%), International $101.4M (+15.2%).
GAAP diluted EPS $0.74 (vs -$0.08 YoY); adjusted diluted EPS $0.71 (vs $0.45 YoY).
Gross margin 67.8% (up 1250 bps); adjusted gross margin 67.3% (up 120 bps).
Raised FY2023 revenue guidance to 26-27% growth; total Omnipod growth 29-30%.
FDA cleared Omnipod 5 iOS App; limited market release early 2024; Omnipod 5 with G7 also early 2024.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

INSULET CORP reported the three months ended September 30, 2023 results: revenue $432.7 million, net income $51.9 million, EPS $0.74 per diluted share. Guidance raised.

Period: the three months ended September 30, 2023
Revenue: $432.7 million
Net income: $51.9 million
EPS: $0.74 per diluted share
Guidance: raised
Result: reported results

Exact text from the filing

Omnipod ® brand of products, today announced financial results for the three months ended September 30, 2023. Third Quarter Financial Highlights: • Third quarter 2023 revenue of $432.7 million, up 27.0%, or 25.1% in constant currency 1 , compared to $340.8 million in the prior year ◦ Total Omnipod revenue of $422.0 million, an increase of 29.4%, or 27.5% in constant

View on SEC.gov

Browse all earnings releases →

INSULET CORP filing history →

Source: SEC EDGAR

accession 0001145197-23-000073

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.